Modified oligonucleotides
dc.assignee | Novartis AG | |
dc.contributor.author | De Mesmaeker, Alain | |
dc.contributor.author | Wendeborn, Sebastian | |
dc.contributor.author | Lebreton, Jaques | |
dc.date.accessioned | 2024-08-16T11:38:20Z | |
dc.date.available | 2024-08-16T11:38:20Z | |
dc.date.issued | 1998-01-08 | |
dc.description.abstract | It is one object of the present invention to provide an oligonucleotide of formula (1): 5'-(U)n-3' in which U is an identical or different radical of a natural or a synthetic nucleoside, wherein the oligonucleotide comprises at least one modified nucleotide dimer comprising two nucleoside analogs connected via an amide-bond that has a certain configuration; the synthesis of these compounds and their use in pharmaceutical preparations. | |
dc.identifier.patent | WO9800434 | |
dc.identifier.uri | https://irf.fhnw.ch/handle/11654/46946 | |
dc.identifier.uri | https://doi.org/10.26041/fhnw-9970 | |
dc.publisher | World Intellectual Property Organization | |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | |
dc.subject.ddc | 500 - Naturwissenschaften und Mathematik | |
dc.title | Modified oligonucleotides | |
dc.type | 12 - Patent | |
dspace.entity.type | Publication | |
fhnw.InventedHere | No | |
fhnw.affiliation.hochschule | Hochschule für Life Sciences FHNW | de_CH |
fhnw.affiliation.institut | Institut für Chemie und Bioanalytik | de_CH |
relation.isAuthorOfPublication | 931d1ba8-5284-4fea-9c44-3ebcc003d638 | |
relation.isAuthorOfPublication.latestForDiscovery | 931d1ba8-5284-4fea-9c44-3ebcc003d638 |
Dateien
Originalbündel
1 - 1 von 1
- Name:
- WO9800434A1_Original_document_20240806114709.pdf
- Größe:
- 4.02 MB
- Format:
- Adobe Portable Document Format
Lizenzbündel
1 - 1 von 1
Kein Vorschaubild vorhanden
- Name:
- license.txt
- Größe:
- 2.66 KB
- Format:
- Item-specific license agreed upon to submission
- Beschreibung: